What Do Chinese Investigators, Reviewers Really Want?
This article was originally published in PharmAsia News
Executive Summary
The rules are tightening up requirements and study sponsors are increasingly competing for the attention of primary investigators at limited clinical trial sites, while changing regulatory thinking is complicating the issue. How can study success be ensured in this environment?